Bristol Myers Strikes Up To $2.3B Avidity Cardio Partnership
By Al Barbarino · November 28, 2023, 2:02 PM EST
Bristol Myers Squibb has struck a research partnership with Avidity Biosciences Inc. that could see the biopharmaceutical giant funnel up to $2.3 billion into the discovery, development and commercialization of certain treatments for cardiovascular...
To view the full article, register now.